Prognostic factors in a multicenter study for treatment of acute lymphoblastic leukemia in adults.

Abstract:

:In a prospective multicenter study, 368 acute lymphoblastic leukemia (ALL) patients aged 15 to 65 years were treated with an intensified induction and reinduction regimen; 272 (73.9%) achieved complete remission (CR). The median remission duration (MRD) is 24.3 months, and the probability of being in continuous CR (CCR) at greater than 5 years is .37. The median survival for all 368 patients is 27.5 months, and the probability of being alive at 5 years is .39. For the 272 patients in remission the median survival is 58.4 months, and the probability of being alive at 5 years is .49. A lower CR rate was seen for patients with bleeding at diagnosis or with splenomegaly/hepatosplenomegaly. The prognostic factors unfavorable for remission duration were time to CR greater than 4 weeks v less than 4 weeks (P = .0002), age greater than 35 years v less than 35 years (P = .0008), leukocyte count greater than 30,000/microL v less than 30,000/microL (P = .0112), and null ALL v common ALL (c-ALL)/T cell ALL (T-ALL) (P = .05). The remission duration correlated strongly (P = .0001) with the number of these independent prognostic factors. In patients with none of these adverse factors the MRD has not yet been reached, with one adverse factor the MRD is 21.9 months, and with two or three adverse factors the MRD is only 9.6 months. For the immunologic subtype T-ALL, the probability of being in CCR at greater than 5 years is .55; for c-ALL, .34; and for null ALL, .24. According to these results, patients were stratified into a low-risk group with a CCR rate of .62 and a high-risk group with a CCR rate of .28, with the latter now allocated to either further chemotherapy or bone marrow transplantation in first remission.

journal_name

Blood

journal_title

Blood

authors

Hoelzer D,Thiel E,Löffler H,Büchner T,Ganser A,Heil G,Koch P,Freund M,Diedrich H,Rühl H

subject

Has Abstract,Author List Incomplete

pub_date

1988-01-01 00:00:00

pages

123-31

issue

1

eissn

0006-4971

issn

1528-0020

journal_volume

71

pub_type

杂志文章

相关文献

BLOOD文献大全
  • Lysosome-associated small Rab GTPase Rab7b negatively regulates TLR4 signaling in macrophages by promoting lysosomal degradation of TLR4.

    abstract::Toll-like receptor 4 (TLR4) initiates both myeloid differentiation factor 88 (MyD88)-dependent and Toll/interleukin (IL)-1R domain-containing adapter, inducing interferon (IFN)-beta-dependent signaling, leading to production of proinflammatory mediators and type I interferon (IFN) to eliminate pathogens. However, unco...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2007-01-066027

    authors: Wang Y,Chen T,Han C,He D,Liu H,An H,Cai Z,Cao X

    更新日期:2007-08-01 00:00:00

  • In vitro platelet abnormality in adenosine deaminase deficiency and severe combined immunodeficiency.

    abstract::The platelets of an infant with severe combined immune deficiency and adenosine deaminase deficiency showed markedly diminished responses to ADP-induced aggregation in vitro. This abnormality was corrected by the addition of purified adenosine deaminase in vitro. Exogenous adenosine added to platelet-rich plasma cause...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Lee CH,Evans SP,Rozenberg MC,Bagnara AS,Ziegler JB,Van der Weyden MB

    更新日期:1979-03-01 00:00:00

  • Efficacy of the farnesyl transferase inhibitor R115777 in chronic myeloid leukemia and other hematologic malignancies.

    abstract::We investigated the clinical activity of the farnesyl transferase inhibitor R115777 in 22 patients with chronic myelogenous leukemia (CML) in chronic, accelerated, or blastic phase and in 8 patients with myelofibrosis (MF) and 10 patients with multiple myeloma (MM). R115777 was administered at 600 mg orally twice dail...

    journal_title:Blood

    pub_type: 临床试验,杂志文章

    doi:10.1182/blood-2002-07-1973

    authors: Cortes J,Albitar M,Thomas D,Giles F,Kurzrock R,Thibault A,Rackoff W,Koller C,O'Brien S,Garcia-Manero G,Talpaz M,Kantarjian H

    更新日期:2003-03-01 00:00:00

  • 2-Chlorodeoxyadenosine: an effective new agent for the treatment of chronic lymphocytic leukemia.

    abstract::2-Chlorodeoxyadenosine, a new lymphocyte-selective, anti-neoplastic drug was administered to 18 patients with advanced chronic lymphocytic leukemia of B-cell origin. All patients were resistant to conventional treatment. A total of 44 courses of 2-chlorodeoxyadenosine were completed with minimal toxicity. An overall r...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Piro LD,Carrera CJ,Beutler E,Carson DA

    更新日期:1988-09-01 00:00:00

  • Hematopoietic stem cell transplantation for de novo erythroleukemia: a study of the European Group for Blood and Marrow Transplantation (EBMT).

    abstract::De novo erythroleukemia (EL) is a rare disease. Reported median survival are poor and vary from 4 to 14 months. The value of hematopoietic stem cell transplantation (HSCT) for EL is unknown. This EBMT registry study reports on the largest series of patients with EL treated with HSCT in first complete remission-103 aut...

    journal_title:Blood

    pub_type: 杂志文章,多中心研究

    doi:10.1182/blood.V100.9.3135

    authors: Fouillard L,Labopin M,Gorin NC,Polge E,Prentice HG,Meloni G,Reiffers J,Pigneux A,Willemze R,Schattenberg A,Sica S,Lagrange M,Fenneteau O,Perot C,Frassoni F,Acute Leukemia Working Party of the EBMT.

    更新日期:2002-11-01 00:00:00

  • Bedside filtration of blood products in the prevention of HLA alloimmunization--a prospective randomized study. Alloimmunisation Study Group.

    abstract::To test the efficacy of poststorage bedside leucodepletion of blood products in the prevention of primary HLA alloimmunization and its clinical sequelae, 172 patients with hematologic malignancy requiring intensive red blood cell and platelet support were randomized to receive either standard or filtered red blood cel...

    journal_title:Blood

    pub_type: 临床试验,杂志文章,多中心研究,随机对照试验

    doi:

    authors: Williamson LM,Wimperis JZ,Williamson P,Copplestone JA,Gooi HC,Morgenstern GR,Norfolk DR

    更新日期:1994-05-15 00:00:00

  • Proliferative state of blast cell progenitors in acute myeloblastic leukemia (AML).

    abstract::Peripheral blood from patients with acute myeloblastic leukemia (AML) contains cells capable of giving rise to colonies in culture when stimulated by media conditioned by leukocytes (LCM) in the presence of phytohemagglutinin (PHA). Two types of colonies are recognized with high frequency: The first grows in the prese...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Minden MD,Till JE,McCulloch EA

    更新日期:1978-09-01 00:00:00

  • Analysis of TNF-receptor and ligand superfamily molecules in patients with lymphoproliferative disease of granular lymphocytes.

    abstract::In 21 patients with lymphoproliferative disease of granular lymphocytes (LDGL), we investigated the expression and the function of molecules belonging to TNF-receptor and TNF-ligand superfamilies (CD30/CD30L; CD40/CD40L; CD27/CD70; Fas [CD95]/FasL[CD95L]). Fourteen patients were characterized by a proliferation of gra...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Zambello R,Trentin L,Facco M,Siviero M,Galvan S,Piazza F,Perin A,Agostini C,Semenzato G

    更新日期:2000-07-15 00:00:00

  • Polyclonal hematopoietic reconstitution in leukemia patients at remission after suppression of specific gene rearrangements.

    abstract::Clonality studies of hematopoietic reconstitution after remission were performed in 24 female patients (pts) with leukemias characterized by specific molecular markers. At diagnosis, 13 pts had promyelocytic leukemia (PML) retinoic acid receptor-alpha (RAR-alpha)-rearranged acute promyelocytic leukemia (APL), 8 Philad...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Lo Coco F,Pelicci PG,D'Adamo F,Diverio D,Alimena G,Montefusco E,Arcese W,Avvisati G,De Felice L,Meloni G

    更新日期:1993-07-15 00:00:00

  • Effect of intravenous gammaglobulin on circulating and platelet-bound antibody in immune thrombocytopenia.

    abstract::Ten patients with idiopathic thrombocytopenic purpura (ITP) were studied before and following a rise in circulating platelets subsequent to infusions of intravenous gammaglobulin (400 mg/kg/day x 5 days). We quantitated the amount of circulating IgG capable of binding to normal donor platelets in vitro using an 125I-m...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Barbano G,Saleh MN,Mori PG,LoBuglio AF,Shaw DR

    更新日期:1989-02-15 00:00:00

  • Neutrophil and monocyte adherence to and migration across monolayers of cytokine-activated endothelial cells: the contribution of CD18, ELAM-1, and VLA-4.

    abstract::Pretreatment of endothelial cells with cytokines enhances the adherence of leukocytes, a process that is mediated by surface proteins expressed on both cell types. A three-dimensional model system for the simultaneous determination of leukocyte adherence and migration was used to study the contribution of CD11/CD18, e...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Hakkert BC,Kuijpers TW,Leeuwenberg JF,van Mourik JA,Roos D

    更新日期:1991-11-15 00:00:00

  • Antibodies to human T-lymphotropic virus type III (HTLV-III) in saliva of acquired immunodeficiency syndrome (AIDS) patients and in persons at risk for AIDS.

    abstract::Whole saliva samples collected from available people at risk in Boston for infection with human T-lymphotropic virus type III (HTLV-III/LAV), from late 1984 through early 1985, were analyzed for the presence of antibodies to viral proteins. Fourteen of 20 (70%) acquired immunodeficiency syndrome (AIDS) patients and 14...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Archibald DW,Zon L,Groopman JE,McLane MF,Essex M

    更新日期:1986-03-01 00:00:00

  • G-CSF receptor activation of the Src kinase Lyn is mediated by Gab2 recruitment of the Shp2 phosphatase.

    abstract::Src activation involves the coordinated regulation of positive and negative tyrosine phosphorylation sites. The mechanism whereby receptor tyrosine kinases, cytokine receptors, and integrins activate Src is not known. Here, we demonstrate that granulocyte colony-stimulating factor (G-CSF) activates Lyn, the predominan...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2009-12-261636

    authors: Futami M,Zhu QS,Whichard ZL,Xia L,Ke Y,Neel BG,Feng GS,Corey SJ

    更新日期:2011-07-28 00:00:00

  • Acute cholesterol depletion impairs functional expression of tissue factor in fibroblasts: modulation of tissue factor activity by membrane cholesterol.

    abstract::Cholesterol, in addition to providing rigidity to the fluid membrane, plays a critical role in receptor function, endocytosis, recycling, and signal transduction. In the present study, we examined the effect of membrane cholesterol on functional expression of tissue factor (TF), a cellular receptor for clotting factor...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2004-03-0990

    authors: Mandal SK,Iakhiaev A,Pendurthi UR,Rao LV

    更新日期:2005-01-01 00:00:00

  • Factor VIII-induced superaggregation of human platelets.

    abstract::High concentrations of bovine factor VIII cause clumping of platelets into a few very large aggregates. This response is termed superaggregation. It is distinct from factor-VIII-induced agglutination but is also independent of both extracellular calcium ions and platelet energy metabolism. Neither agglutinating lectin...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Kirby EP,Mills DC,Holmsen H,Russo M

    更新日期:1982-12-01 00:00:00

  • A new series of vitamin D analogs is highly active for clonal inhibition, differentiation, and induction of WAF1 in myeloid leukemia.

    abstract::The active form of vitamin D3 [1 alpha, 25-dihydroxyvitamin-D3 (1 alpha, 25(OH)2D3)] modulates the proliferation and differentiation of hematopoietic cells. Analogs of 1 alpha, 25(OH)2D3 that have greater potency may have the potential as adjuvant therapy for high-risk patients in remission for acute myelogenous leuke...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Munker R,Kobayashi T,Elstner E,Norman AW,Uskokovic M,Zhang W,Andreeff M,Koeffler HP

    更新日期:1996-09-15 00:00:00

  • One-day ex vivo culture allows effective gene transfer into human nonobese diabetic/severe combined immune-deficient repopulating cells using high-titer vesicular stomatitis virus G protein pseudotyped retrovirus.

    abstract::Retrovirus-mediated gene transfer into long-lived human pluripotent hematopoietic stem cells (HSCs) is a widely sought but elusive goal. A major problem is the quiescent nature of most HSCs, with the perceived requirement for ex vivo prestimulation in cytokines to induce stem cell cycling and allow stable gene integra...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Rebel VI,Tanaka M,Lee JS,Hartnett S,Pulsipher M,Nathan DG,Mulligan RC,Sieff CA

    更新日期:1999-04-01 00:00:00

  • Targeting TORC2 in multiple myeloma with a new mTOR kinase inhibitor.

    abstract::Although preclinical work with rapalogs suggests potential in treatment of multiple myeloma (MM), they have been less successful clinically. These drugs allostearically inhibit the mammalian target of rapamycin kinase primarily curtailing activity of the target of rapamycin complex (TORC)1. To assess if the mammalian ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2010-05-285726

    authors: Hoang B,Frost P,Shi Y,Belanger E,Benavides A,Pezeshkpour G,Cappia S,Guglielmelli T,Gera J,Lichtenstein A

    更新日期:2010-11-25 00:00:00

  • Mcl-1 expression in human neutrophils: regulation by cytokines and correlation with cell survival.

    abstract::Human neutrophils possess a very short half-life because they constitutively undergo apoptosis. Cytokines, such as granulocyte-macrophage colony-stimulating factor (GM-CSF), and other agents can rescue neutrophils from apoptosis but the molecular mechanisms involved in this rescue are undefined. Here, we show by Weste...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Moulding DA,Quayle JA,Hart CA,Edwards SW

    更新日期:1998-10-01 00:00:00

  • Molecular profiling of diffuse large B-cell lymphoma identifies robust subtypes including one characterized by host inflammatory response.

    abstract::Diffuse large B-cell lymphoma (DLBCL) is a heterogeneous disease with recognized variability in clinical outcome, genetic features, and cells of origin. To date, transcriptional profiling has been used to highlight similarities between DLBCL tumor cells and normal B-cell subtypes and associate genes and pathways with ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2004-07-2947

    authors: Monti S,Savage KJ,Kutok JL,Feuerhake F,Kurtin P,Mihm M,Wu B,Pasqualucci L,Neuberg D,Aguiar RC,Dal Cin P,Ladd C,Pinkus GS,Salles G,Harris NL,Dalla-Favera R,Habermann TM,Aster JC,Golub TR,Shipp MA

    更新日期:2005-03-01 00:00:00

  • CCAAT/Enhancer binding proteins repress the leukemic phenotype of acute myeloid leukemia.

    abstract::CCAAT/enhancer binding proteins (C/EBPs) are a family of factors that regulate cell growth and differentiation. These factors, particularly C/EBPalpha and C/EBPepsilon, have important roles in normal myelopoiesis. In addition, loss of C/EBP activity appears to have a role in the pathogenesis of myeloid disorders inclu...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2002-05-1374

    authors: Truong BT,Lee YJ,Lodie TA,Park DJ,Perrotti D,Watanabe N,Koeffler HP,Nakajima H,Tenen DG,Kogan SC

    更新日期:2003-02-01 00:00:00

  • Heparin and heparan sulfate bind interleukin-10 and modulate its activity.

    abstract::Glycosaminoglycans (GAG) are a group of negatively charged molecules that have been shown to bind and directly regulate the bioactivity of growth factors and cytokines such as basic fibroblast growth factor, transforming growth factor-beta, IL-7, and interferon-gamma. The ability of GAG to interact with human IL-10 (h...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Salek-Ardakani S,Arrand JR,Shaw D,Mackett M

    更新日期:2000-09-01 00:00:00

  • Activation of the human immunodeficiency virus-1 long terminal repeat by respiratory burst oxidants of neutrophils.

    abstract::The human immunodeficiency virus type 1 (HIV-1) long terminal repeat (LTR) introduced in association with the luciferase reporter gene into Jurkat T cells was strongly activated by a combination of human neutrophils and phorbol myristate acetate (PMA). Activation was not observed when normal neutrophils were replaced ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Klebanoff SJ,Headley CM

    更新日期:1999-01-01 00:00:00

  • CD19-targeted CAR T-cell therapeutics for hematologic malignancies: interpreting clinical outcomes to date.

    abstract::Adoptive transfer of T cells genetically modified to express chimeric antigen receptors (CARs) targeting CD19 has produced impressive results in treating patients with B-cell malignancies. Although these CAR-modified T cells target the same antigen, the designs of CARs vary as well as several key aspects of the clinic...

    journal_title:Blood

    pub_type: 杂志文章,评审

    doi:10.1182/blood-2016-02-629063

    authors: Park JH,Geyer MB,Brentjens RJ

    更新日期:2016-06-30 00:00:00

  • A hematopoietic cell L-selectin ligand that is distinct from PSGL-1 and displays N-glycan-dependent binding activity.

    abstract::Human hematopoietic progenitor cells express L-selectin and also express PSGL-1, a ligand for all selectins. Using a shear-based adhesion assay, a hematopoietic cell L-selectin ligand (HCLL) that is expressed on the hematopoietic cell line KG1a and on normal human hematopoietic progenitors was previously identified. T...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Sackstein R,Dimitroff CJ

    更新日期:2000-10-15 00:00:00

  • A platelet membrane glycoprotein (GP) deficiency in healthy blood donors: Naka- platelets lack detectable GPIV (CD36).

    abstract::It has recently been shown that the Naka antigen, which is absent in 3% to 11% of Japanese blood donors, is expressed on platelet glycoprotein IV (GPIV; CD36) (Tomiyama et al, BLOOD, 75:684, 1990). In the present studies, flow cytometry was used to distinguish differences in the reactivity of Naka+ and Naka- platelets...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Yamamoto N,Ikeda H,Tandon NN,Herman J,Tomiyama Y,Mitani T,Sekiguchi S,Lipsky R,Kralisz U,Jamieson GA

    更新日期:1990-11-01 00:00:00

  • Preclinical efficacy of humanized, non-FcγR-binding anti-CD3 antibodies in T-cell acute lymphoblastic leukemia.

    abstract::T-cell acute lymphoblastic leukemia (T-ALL) is an aggressive malignancy that accounts for ∼20% of ALL cases. Intensive chemotherapy regimens result in cure rates >85% in children and <50% in adults, warranting a search of novel therapeutic strategies. Although immune-based therapies have tremendously improved the trea...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.2019003801

    authors: Tran Quang C,Zaniboni B,Humeau R,Lengliné E,Dourthe ME,Ganesan R,Singh S,Scheer JM,Asnafi V,Ghysdael J

    更新日期:2020-09-10 00:00:00

  • A novel role for IL-22R1 as a driver of inflammation.

    abstract::The interleukin (IL)-22R1 chain of the heterodimeric IL-22 receptor is not expressed on normal leukocytes, but this receptor is expressed on T cells from anaplastic lymphoma kinase-positive (ALK(+)) anaplastic large cell lymphoma (ALCL) patients. To investigate the consequences of aberrant expression of this receptor ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2010-05-285908

    authors: Savan R,McFarland AP,Reynolds DA,Feigenbaum L,Ramakrishnan K,Karwan M,Shirota H,Klinman DM,Dunleavy K,Pittaluga S,Anderson SK,Donnelly RP,Wilson WH,Young HA

    更新日期:2011-01-13 00:00:00

  • Isolation of microtubule coils from normal human platelets.

    abstract::The blood platelet is the only human cell known to have a circumferential band of microtubules. However, the mechanisms involved in assembly of the multi-looped coil, its interaction with the cell membrane to support discoid shape, and constriction into tight rings around centrally concentrated organelles in activated...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: White JG,Krumwiede M

    更新日期:1985-04-01 00:00:00

  • Mast cell hyperplasia, B-cell malignancy, and intestinal inflammation in mice with conditional expression of a constitutively active kit.

    abstract::Signaling through the receptor tyrosine kinase kit controls proliferation and differentiation of hematopoietic precursor cells and mast cells. Somatic point mutations of the receptor that constitutively activate kit signaling are associated with mastocytosis and various hematopoietic malignancies. We generated a Cre/l...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2008-11-189605

    authors: Gerbaulet A,Wickenhauser C,Scholten J,Peschke K,Drube S,Horny HP,Kamradt T,Naumann R,Müller W,Krieg T,Waskow C,Hartmann K,Roers A

    更新日期:2011-02-10 00:00:00